Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Total Liabilities
Based on the latest financial reports, Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) has total liabilities worth €204.50 Million EUR (≈ $239.09 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Eckert & Ziegler Strahlen- und Medizinte to see how much of total assets are deployed in long-term investments.
Eckert & Ziegler Strahlen- und Medizintechnik AG - Total Liabilities Trend (2013–2025)
This chart illustrates how Eckert & Ziegler Strahlen- und Medizintechnik AG's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Eckert & Ziegler Strahlen- und Medizinte.
Eckert & Ziegler Strahlen- und Medizintechnik AG Competitors by Total Liabilities
The table below lists competitors of Eckert & Ziegler Strahlen- und Medizintechnik AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
VNDIRECT Securities Corp
VN:VND
|
Vietnam | ₫28.43 Trillion |
|
Beijing Qianjing Landscape Co
SHG:603778
|
China | CN¥2.17 Billion |
|
Janux Therapeutics Inc
NASDAQ:JANX
|
USA | $86.69 Million |
|
Elevra Lithium Limited
AU:ELV
|
Australia | AU$205.99 Million |
|
PixArt Imaging
TWO:3227
|
Taiwan | NT$4.41 Billion |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101
|
China | CN¥231.16 Million |
|
Yunnan QuakeSafe Seismic Isolation Technologies Co Ltd Class A
SHE:300767
|
China | CN¥571.91 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Eckert & Ziegler Strahlen- und Medizintechnik AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See EUZ equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eckert & Ziegler Strahlen- und Medizintechnik AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eckert & Ziegler Strahlen- und Medizintechnik AG (2013–2025)
The table below shows the annual total liabilities of Eckert & Ziegler Strahlen- und Medizintechnik AG from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €204.50 Million ≈ $239.09 Million |
-5.84% |
| 2024-12-31 | €217.18 Million ≈ $253.91 Million |
+0.89% |
| 2023-12-31 | €215.27 Million ≈ $251.67 Million |
+5.94% |
| 2022-12-31 | €203.21 Million ≈ $237.57 Million |
+30.93% |
| 2021-12-31 | €155.20 Million ≈ $181.45 Million |
+8.47% |
| 2020-12-31 | €143.08 Million ≈ $167.28 Million |
+6.15% |
| 2019-12-31 | €134.79 Million ≈ $157.59 Million |
+28.16% |
| 2018-12-31 | €105.17 Million ≈ $122.96 Million |
+5.73% |
| 2017-12-31 | €99.47 Million ≈ $116.29 Million |
+11.28% |
| 2016-12-31 | €89.39 Million ≈ $104.50 Million |
-2.85% |
| 2015-12-31 | €92.01 Million ≈ $107.57 Million |
-0.90% |
| 2014-12-31 | €92.84 Million ≈ $108.54 Million |
+5.33% |
| 2013-12-31 | €88.14 Million ≈ $103.05 Million |
-- |
About Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories… Read more